Literature DB >> 21644253

Simultaneous analysis of acetaminophen, p-aminophenol and aspirin metabolites by hydrophilic interaction and strong anion exchange capillary liquid chromatography coupled to amperometric detection.

Minmin Zheng1, Yimin Wu, Lanxiang Lu, Kang Ding, Fengxiang Tang, Zian Lin, Xiaoping Wu.   

Abstract

A simple and sensitive method has been developed for the simultaneous determination of polar nonsteroidal pharmaceuticals and metabolites, including acetaminophen, p-aminophenol and several aspirin metabolites (salicylic acid, gentisic acid, salicyluric acid and 2,3-dihydroxybenzoic acid), by capillary liquid chromatography with amperometric detection. Using a capillary monolithic column with mixed mode stationary phases and a mobile phase composed of acetonitrile and Tris buffer, rapid separation of six polar analytes was achieved within 8 min, and a hydrophilic interaction and strong anion exchange separation mechanism were exhibited. Method detection limits of six analytes ranged from 10 to 50 ng/mL. In terms of precision, the intra- and interday relative standard deviation values in all analytes never exceeded 3.1% for migration time and 8.9% for peak areas, respectively. This method provided a simple, rapid and cost-effective approach for the analysis of polar pharmaceuticals. The applicability of the method in pharmacokinetics was verified by spiking human serum samples with the compounds and analyzing the recoveries.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Amperometric detection; Capillary liquid chromatography; HI/SAX monolithic column; Polar pharmaceuticals and metabolites

Mesh:

Substances:

Year:  2011        PMID: 21644253     DOI: 10.1002/jssc.201100163

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  1 in total

1.  Platinized agarose microspheres as a new modifier in graphite paste electrodes for the electrochemical determination of 4-aminophenol.

Authors:  M Tohidinia; A Biabangard; M Noroozifar
Journal:  RSC Adv       Date:  2020-01-16       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.